Peoples Financial Services Corp’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.65M Sell
18,482
-78
-0.4% -$16.8K 2.01% 9
2026
Q1
$4.04M Sell
18,560
-221
-1% -$49K 1.91% 13
2025
Q4
$4.29M Sell
18,781
-987
-5% -$225K 2% 10
2025
Q3
$4.58M Sell
19,768
-131
-0.7% -$26.7K 2.07% 11
2025
Q2
$3.69M Sell
19,899
-1,876
-9% -$349K 1.83% 11
2025
Q1
$4.56M Sell
21,775
-335
-2% -$65.1K 2.19% 9
2024
Q4
$3.93M Sell
22,110
-164
-0.7% -$30.2K 1.82% 11
2024
Q3
$4.4M Sell
22,274
-2,484
-10% -$464K 1.99% 9
2024
Q2
$4.25M Sell
24,758
-667
-3% -$110K 1.92% 10
2024
Q1
$4.63M Sell
25,425
-1,056
-4% -$182K 2.01% 12
2023
Q4
$4.1M Sell
26,481
-116
-0.4% -$16.9K 1.78% 12
2023
Q3
$3.96M Buy
26,597
+110
+0.4% +$16.1K 1.87% 11
2023
Q2
$3.57M Sell
26,487
-417
-2% -$61.1K 1.6% 14
2023
Q1
$4.29M Sell
26,904
-642
-2% -$98.2K 2% 10
2022
Q4
$4.45M Sell
27,546
-307
-1% -$47.1K 2.08% 12
2022
Q3
$3.74M Sell
27,853
-143
-0.5% -$20.5K 1.93% 13
2022
Q2
$4.29M Sell
27,996
-174
-0.6% -$26.6K 2.03% 10
2022
Q1
$4.57M Sell
28,170
-2,322
-8% -$337K 1.97% 12
2021
Q4
$4.13M Buy
30,492
+891
+3% +$105K 1.61% 14
2021
Q3
$3.19M Sell
29,601
-487
-2% -$55.6K 1.35% 16
2021
Q2
$3.39M Sell
30,088
-85
-0.3% -$9.57K 1.42% 15
2021
Q1
$3.27M Buy
30,173
+204
+0.7% +$21.8K 1.42% 16
2020
Q4
$3.21M Buy
29,969
+1,072
+4% +$103K 1.48% 16
2020
Q3
$2.53M Buy
28,897
+850
+3% +$80K 1.27% 17
2020
Q2
$2.75M Buy
28,047
+3,034
+12% +$267K 1.45% 16
2020
Q1
$1.91M Buy
25,013
+376
+2% +$32K 1.12% 23
2019
Q4
$2.18M Buy
24,637
+1,500
+6% +$125K 1.03% 29
2019
Q3
$1.75M Buy
23,137
+282
+1% +$19.3K 0.88% 35
2019
Q2
$1.66M Buy
22,855
+1,200
+6% +$94.3K 0.84% 37
2019
Q1
$1.75M Buy
21,655
+2,100
+11% +$172K 0.89% 36
2018
Q4
$1.8M Buy
19,555
+150
+0.8% +$13.2K 1.02% 30
2018
Q3
$1.84M Sell
19,405
-225
-1% -$21.3K 0.93% 33
2018
Q2
$1.82M Sell
19,630
-2,725
-12% -$266K 1.02% 30
2018
Q1
$2.12M Sell
22,355
-1,825
-8% -$200K 1.21% 23
2017
Q4
$2.34M Sell
24,180
-100
-0.4% -$9.43K 1.28% 22
2017
Q3
$2.16M Sell
24,280
-100
-0.4% -$7.61K 1.22% 25
2017
Q2
$1.77M Hold
24,380
1.04% 27
2017
Q1
$1.59M Sell
24,380
-350
-1% -$22K 0.95% 31
2016
Q4
$1.53M Sell
24,730
-1,000
-4% -$61K 0.94% 29
2016
Q3
$1.62M Buy
25,730
+1,000
+4% +$64.7K 1.01% 31
2016
Q2
$1.53M Hold
24,730
0.94% 29
2016
Q1
$1.41M Buy
24,730
+1,375
+6% +$76.6K 0.89% 31
2015
Q4
$1.38M Hold
23,355
0.91% 28
2015
Q3
$1.27M Sell
23,355
-50
-0.2% -$3.25K 0.91% 32
2015
Q2
$1.57M Sell
23,405
-1,275
-5% -$83.2K 1.05% 25
2015
Q1
$1.45M Sell
24,680
-25
-0.1% -$1.51K 0.96% 30
2014
Q4
$1.62M Buy
24,705
+3,050
+14% +$192K 1.06% 24
2014
Q3
$1.25M Sell
21,655
-225
-1% -$12.5K 0.85% 33
2014
Q2
$1.24M Sell
21,880
-775
-3% -$40.7K 0.78% 36
2014
Q1
$1.17M Buy
22,655
+5,150
+29% +$260K 0.86% 37
2013
Q4
$925K Buy
+17,505
New +$860K 0.61% 50

Other funds holding ABBV

Peoples Financial Services Corp's ABBV Position: Q2 2026 in Review

Peoples Financial Services Corp reduced its AbbVie (ABBV) stake by 0.42% in Q2 2026, selling an estimated $16.8K and leaving 18,482 shares worth $4.65M. The position accounts for 2.01% of the portfolio, ranked #9.

Peoples Financial Services Corp first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 1,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Peoples Financial Services Corp held 18,482 shares of AbbVie worth $4.65M as of Q2 2026.
  • Peoples Financial Services Corp sold 78 AbbVie shares in Q2 2026, an estimated $16.8K.
  • AbbVie made up 2.01% of Peoples Financial Services Corp's portfolio in Q2 2026, its #9 holding.
  • Peoples Financial Services Corp first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
  • 1,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Peoples Financial Services Corp's 13F filing for Q2 2026, filed 22 Jul 2026.